DOI: 10.1128/JVI.00926-20
Article Information
PubMed
Published By
History
- Received May 11, 2020
- Accepted May 12, 2020
- Published online July 30, 2020.
Copyright & Usage
Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- J.-H. James Ou, Editor, University of Southern California
Article Versions
- Accepted Manuscript version (June 03, 2020).
- You are viewing the most recent version of this article.
Author Information
- Zahra Zahid Pirachaa,b,
- Umar Saeeda,b,
- Jumi Kima,b,
- Hyeonjoong Kwona,b,
- Yong-Joon Chwaea,b,
- Hyun Woong Leec,
- Jin Hong Limd,
- Sun Parka,b,
- Ho-Joon Shina,b and
- Kyongmin Kima,b
- aDepartment of Microbiology, Ajou University School of Medicine, Suwon, South Korea
- bDepartment of Biomedical Science, Graduate School of Ajou University, Suwon, South Korea
- cDepartment of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
- dDepartment of General Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
- Address correspondence to Kyongmin Kim, kimkm{at}ajou.ac.kr.
Citation Piracha ZZ, Saeed U, Kim J, Kwon H, Chwae Y-J, Lee HW, Lim JH, Park S, Shin H-J, Kim K. 2020. An alternatively spliced Sirtuin 2 isoform 5 inhibits hepatitis B virus replication from cccDNA by repressing epigenetic modifications made by histone lysine methyltransferases. J Virol 94:e00926-20. https://doi.org/10.1128/JVI.00926-20.
